SMS Pharmaceuticals has successfully completed its fifth US Food and Drug Administration (US FDA) inspection for its manufacturing facility Unit-II located at Plot No.24 & 24B and 36 & 37, S V Co-operative Industrial Estate, Bachupally, Ranga Reddy District, Hyderabad in state of Telangana. There were no ‘Form 483’ observations issued during the inspection.
SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. They are the single largest producer of anti-ulcer products.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: